Key Account Manager

American Healthcare Company Abbott is the world's eighth-largest independent biotech company. Aiming to provide the community a healthier life full of possibilities, it markets its products in over 160 countries. The company deals in four primary segments namely, established pharmaceutical products, diagnostic products, nutritional products, and vascular products.

Abbott (India):

Abbott India was established in 1910 and is headquartered in Mumbai. The company offers high-quality trusted medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care.

Abbott expertise across product development, sales, manufacturing, and customer service and are committed to rendering reliable, high-quality products with skillful clinical assistance the customers require.

Organization Structure:

Category-wise Products:

• Diabetes Care: Glucose monitoring devices
• Diagnostics: Immunodiagnostic, oncology and clinical chemistry (including the i-Stat)
• Endovascular
• Established Pharmaceuticals (EPD): Branded generic drugs sold exclusively in developing markets
• Medical Devices
• Medical Optics
• Nutrition: Similac, Isomil, and Gain (Baby Nutrition); Ensure and ZonePerfect (adult health products); and Glucerna and Juven (special dietary needs)

Brands:

• Similac
• Pedia Sure
• Pedialyte
• EleCare
• ZonePerfect
• Ensure
• FreeStyle Libre
• FreeStyle
• Glucerna, and more.

Corporate Social Responsibility:

• One Blood Test- "A world-changing idea" Abbott's high sensitive troponin-I blood test has been used throughout Europe in emergency rooms to help aid doctors in the diagnosis of a heart attack.
• Filling a big need within the smallest of us: Irie was born prematurely after 27 weeks. She was suffering from a life-threatening congenital defect called a patent ductus arteriosus, or PDA, which is an opening between two blood vessels leading from the heart that is also present in normally developing fetuses. For most of the babies, that opening closes itself soon after birth. But in some cases- primarily in premature babies such as Irie, it fails to close, making it difficult for babies to breathe normally due to an increased flow of blood to the lungs. With Abbott’s Amplatzer Piccolo™ Occluder, the procedure cured her PDA. After the procedure, Irie was able to breathe on her own within three days and was taken off the ventilator.
• New data shows that the use of Abbott's FreeStyle Libre system significantly reduces HBA1C levels in people living with Type 2 Diabetes.

Client Portfolio:

Some of the major clients of Abbott are:

• Baxter International Inc.
• Express Scripts Holding Co.
• Kroger Co
• Aetna Inc
• Aflac Incorporated
• Anthem Inc.
• Cigna Corporation
• Metlife Inc.
• United Healthgroup Inc.

Mergers and Acquisitions:

Abbott has acquired over 36 organizations:

• In Jan 2019, Abbott acquired Cephea Valve Technologies: According to Michael Dale, vice president of Abbott's structural heart business- The acquisition of Cephea builds on Abbott's strong position in structural heart therapies and is consistent with our strategy to develop comprehensive treatments for people with mitral valve disease.
• In April 2016, Abbott acquired St. Jude Medical as a measure to strengthen its global medical device control while offering innovative products to approach more areas of care, in more physicians' clinics and hospitals around the globe.
• In April 2016, Abbott acquired Kalila Medical.
• In Feb 2016, Abbott acquired Alere.

News and Facts:

• Offering a smarter approach to 24/7 Heart Monitoring for people with irregular heartbeats Abbott launched next-generation detection technology in Europe and the U.S. in May 2019.
• For breakthrough HIV point-of-care test, Abbott receives WHO prequalification approval in May 2019.
• To address NonCommunicable Diseases (NCDs) in humanitarian settings, the Abbott Fund, CARE and Abbott launched a partnership in June 2019.
• To aid in the diagnosis of Diabetes, the first ever rapid point-of-care hba1c test launched by Abbott in June 2019.